invitros

  Invitros participated in the LMCE 2024 Exhibition and held an Education Workshop successfully. LMCE 2024 is the largest international academic conference in the field of laboratory medicine in Korea and Asia, hosted by the Korean Society for Laboratory Medicine. It took place over three days from Wednesday, September 25 to Friday, September 27, 2024.  Many visitors stopped by our exhibition booth, and you can experience the event below.  We showcased our lineup of immunodiagnostics and molecular diagnostics products, which garnered significant interest from attendees. For more detailed information about our products, please visit the link below:< Invitros' LMCE 2024 Online Exhibition >   Additionally, on Thursday, September 26, at 8:00 a.m., Invitros hosted an Education Workshop.  The workshop, titled “A Key Role of Interferon Gamma Release Assay for Tuberculosis Disease Control”, was well-attended despite the early hour. We would like to express our gratitude to all who participated.   Thanks to your support, Invitros’ LMCE 2024 exhibition and Education Workshop was finished successfully. We sincerely thank everyone who attended and look forward to your continued interest and support in the future. Thank you. 

 LG Chem has launched a reagent that can check 93 allergy-causing substances, up sharply from the current 62, the company said Thursday.

In 2008, LG Chem released the “AdvanSure™ AlloScreen reagent,” a multi-drug substance-testing product, for the first time in Korea, through research and development on the diagnosis of allergies with Yonsei University Medical School.

The products launched this year added house dust mites, pollen allergies, and substances unique to Koreans through continuous research.

In particular, this reagent expands from 62 existing elements, enabling 93 kinds of materials to be inspected simultaneously with a drop of blood in three hours, saving time and cost of inspection, as well as providing food and the respiratory origin, while identifying the cause of the substance.

Allergies are types of autoimmune diseases that cause hypersensitivity reactions to external substances. It causes allergic asthma, eczema, and rhinitis, with symptoms such as a runny nose, and itchiness that distributes to many patients throughout the world.

Methods for treating allergies include the use of antihistamines, steroids, and immunotherapy, the most efficient and easiest way.

The domestic market is estimated to be about 25 billion won ($21 million), with the number of patients increasing every year due to the effects of fine dust and environmental hormones. Allergies caused by two or more causes are also increasing, making it necessary to know what causes allergens before they appear, the company said. (2017.08.10)

[Link: https://www.koreabiomed.com/news/articleView.html?idxno=1055]